Inhaled fluticasone reduces sputum inflammatory indices in <font color="red">severe_4</font> <font color="red">bronchiectasis_5</font> <font color="red">._5</font> 
<br>
<br> Although corticosteroid therapy might be clinically beneficial for <font color="red">bronchiectasis_2</font> <font color="red">,_2</font> very little is known of its effects on the inflammatory and infective markers in <font color="red">bronchiectasis_1</font> <font color="red">._1</font> We have therefore performed a double - blind , placebo - controlled study to evaluate the effects of a 4-wk administration of inhaled fluticasone in <font color="red">bronchiectasis_1</font> <font color="red">._1</font> <font color="red">Twenty_7</font> <font color="red">-_7</font> <font color="red">four_7</font> <font color="red">patients_7</font> <font color="red">(_7</font> <font color="red">12_7</font> <font color="red">female_7</font> <font color="red">;_7</font> <font color="red">mean_7</font> <font color="red">age_7</font> <font color="red">51_7</font> <font color="red">yr_7</font> <font color="red">)_7</font> <font color="red">were_3</font> <font color="red">randomized_3</font> <font color="red">into_2</font> <font color="red">receiving_2</font> <font color="red">either_2</font> <font color="red">inhaled_2</font> <font color="red">fluticasone_2</font> <font color="red">(_2</font> <font color="red">500_2</font> <font color="red">microgram_2</font> <font color="red">twice_2</font> <font color="red">daily_2</font> <font color="red">)_2</font> <font color="red">via_2</font> <font color="red">the_2</font> <font color="red">Accuhaler_2</font> <font color="red">device_2</font> <font color="red">(_2</font> <font color="red">n_2</font> <font color="red">=_2</font> <font color="red">12_2</font> <font color="red">)_2</font> <font color="red">or_2</font> <font color="red">placebo_2</font> <font color="red">._2</font> At each visit , spirometry , 24-h sputum volume , sputum leukocyte density , bacterial densities , and concentrations of interleukin ( IL)-1beta , IL-8 , tumor necrosis factor - alpha ( TNF - alpha ) , and leukotriene B4 ( LTB4 ) were determined . There was a significant ( p < 0.05 ) decrease in sputum leukocyte density and IL-1beta , IL-8 , and LTB4 after fluticasone treatment . The fluticasone group had one and the placebo group three episodes of exacerbation . There were no significant changes in spirometry ( p > 0.05 ) or any reported adverse reactions in either group . The results of this study show that high - dose fluticasone is effective in reducing the sputum inflammatory indices in <font color="red">bronchiectasis_1</font> . Large - scale and long - term studies are indicated to evaluate the effects of inhaled steroid therapy on the inflammatory components in <font color="red">bronchiectasis_2</font> <font color="red">._2</font>